跳至主要内容
临床试验/NCT01644487
NCT01644487已完成不适用

Efficacy of Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries Following Successful Balloon Angioplasty Trial (Korean Vascular Intervention Multicenter Study)

Korea University Guro Hospital2 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2012年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
122
试验地点
2
主要终点
Angiographic binary restenosis rate

研究概览

简要总结

The objectives of this study are to compare directly conventional balloon angioplasty alone versus. balloon angioplasty with routine stenting - that is, to determine whether angioplasty with self-expanding stent is superior to conventional balloon angioplasty - in the infrapopliteal arterial occlusive lesions of critical limb ischemia patients by collecting and analyzing the cases of each patient group in a prospective multicenter randomized clinical trial, and to clarify main factors affecting mid- and long-term clinical effects of angioplasty with self-expanding stent in the infrapopliteal arteries.

Hypothesis: Balloon PTA followed by routine stenting with self-expanding nitinol stent in critical limb ischemia patients with infrapopliteal arterial occlusive lesions is superior to conventional PTA in the aspect of vascular restenosis rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic critical limb ischemia (Rutherford 4 - 6)
  • Patients with signed informed consent
  • Target lesion length < 8 cm by angiographic estimation
  • Stenosis of >50% or occlusive atherosclerotic lesion of the ipsilateral infrapopliteal artery
  • Reference vessel diameter should be 2.0-4.5 mm

排除标准

  • Patient has a known allergy to heparin, aspirin, or other anticoagulant/antiplatelet therapies or a bleeding diatheses or is unable, or unwilling, to tolerate such therapies
  • Patient takes warfarin
  • Patient has a history of previous life-threatening contrast media reaction
  • Patient is currently enrolled in another investigational device or drug trial
  • Patient is currently breast-feeding, is pregnant, or intends to become pregnant
  • Patient is mentally ill or retarded
  • Acute critical limb ischemia
  • Major bleeding history within prior 2 months
  • Severe hepatic dysfunction (> 3 times normal reference values)
  • Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis
  • Life expectancy <1 year due to comorbidity
  • Reference segment diameter is not suitable for available stent design
  • Previously implanted stent(s) or PTA at the same lesion site
  • Inflow-limiting arterial lesions left untreated

研究组 & 干预措施

Primary stenting

Experimental

A group of patients who will undergo subsequent primary stenting following successful conventional balloon angioplasty

干预措施: self-expanding nitinol stent (Device)

Balloon only

Active Comparator

A group of patients who will undergo routine conventional balloon angioplasty alone without stenting

干预措施: balloon angioplasty (Device)

结局指标

主要结局

Angiographic binary restenosis rate

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seung Woon Rha

Professor

Korea University Guro Hospital

研究点 (2)

Loading locations...

相似试验